Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kairos Pharma (KAPA) Times Interest Earned (2024)

Kairos Pharma (KAPA) has disclosed Times Interest Earned for 1 consecutive years, with -$13.77 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Times Interest Earned changed N/A year-over-year to -$13.77, compared with a TTM value of -$7.1 through Jun 2025, changed N/A, and an annual FY2024 reading of -$3.5, up 91.43% over the prior year.
  • Times Interest Earned was -$13.77 for Q4 2024 at Kairos Pharma, down from -$0.72 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$0.72 in Q3 2024 and bottomed at -$18.5 in Q2 2024.